C-reactive protein – My perspective on its first half century, 1930-1982

C-reactive protein (CRP) was discovered in 1930 in the sera of patients during the acute phase of pneumococcal pneumonia and was so named because it bound to the C-polysaccharide of the pneumococcal cell wall. During the next half century many questions raised by this discovery were answered. Phosph...

Full description

Bibliographic Details
Main Author: Irving Kushner
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1150103/full
_version_ 1811161539162406912
author Irving Kushner
author_facet Irving Kushner
author_sort Irving Kushner
collection DOAJ
description C-reactive protein (CRP) was discovered in 1930 in the sera of patients during the acute phase of pneumococcal pneumonia and was so named because it bound to the C-polysaccharide of the pneumococcal cell wall. During the next half century many questions raised by this discovery were answered. Phosphorylcholine was found to be the moiety of the C-polysaccharide to which CRP bound. The molecular structure of CRP was elucidated: five identical subunits arranged in cyclic symmetry, giving rise to the term pentraxin. Initially felt to be not normally present in the blood, CRP was found to be a component of normal serum in trace amounts. Its site of origin was determined to be the hepatocyte. It became clear that the presumed humoral mediator responsible for CRP induction was of leukocytic origin. Binding of CRP to its ligand activated the complement system, one of the important effector mechanisms of innate immunity. CRP was found to stimulate phagocytosis of some bacterial species via binding to Fc receptors and was found to be protective in vivo against the pneumococcus in mice. It appeared likely that a related function of CRP was clearance of necrotic tissue. CRP was recognized as being a highly evolutionary conserved molecule. Its discovery during the acute phase of pneumococcal pneumonia led to its being dubbed an acute phase protein. What we today call “the acute phase response”, refers to the large number of behavioral, physiologic, biochemical, and nutritional changes that occur during inflammatory states.
first_indexed 2024-04-10T06:15:58Z
format Article
id doaj.art-409f724b11b04720a5008f8b9ba3fdfd
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-10T06:15:58Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-409f724b11b04720a5008f8b9ba3fdfd2023-03-02T06:58:55ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-03-011410.3389/fimmu.2023.11501031150103C-reactive protein – My perspective on its first half century, 1930-1982Irving KushnerC-reactive protein (CRP) was discovered in 1930 in the sera of patients during the acute phase of pneumococcal pneumonia and was so named because it bound to the C-polysaccharide of the pneumococcal cell wall. During the next half century many questions raised by this discovery were answered. Phosphorylcholine was found to be the moiety of the C-polysaccharide to which CRP bound. The molecular structure of CRP was elucidated: five identical subunits arranged in cyclic symmetry, giving rise to the term pentraxin. Initially felt to be not normally present in the blood, CRP was found to be a component of normal serum in trace amounts. Its site of origin was determined to be the hepatocyte. It became clear that the presumed humoral mediator responsible for CRP induction was of leukocytic origin. Binding of CRP to its ligand activated the complement system, one of the important effector mechanisms of innate immunity. CRP was found to stimulate phagocytosis of some bacterial species via binding to Fc receptors and was found to be protective in vivo against the pneumococcus in mice. It appeared likely that a related function of CRP was clearance of necrotic tissue. CRP was recognized as being a highly evolutionary conserved molecule. Its discovery during the acute phase of pneumococcal pneumonia led to its being dubbed an acute phase protein. What we today call “the acute phase response”, refers to the large number of behavioral, physiologic, biochemical, and nutritional changes that occur during inflammatory states.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1150103/fullC-reactive proteinacute phase responsecomplementphagocytosisRockefeller Institute
spellingShingle Irving Kushner
C-reactive protein – My perspective on its first half century, 1930-1982
Frontiers in Immunology
C-reactive protein
acute phase response
complement
phagocytosis
Rockefeller Institute
title C-reactive protein – My perspective on its first half century, 1930-1982
title_full C-reactive protein – My perspective on its first half century, 1930-1982
title_fullStr C-reactive protein – My perspective on its first half century, 1930-1982
title_full_unstemmed C-reactive protein – My perspective on its first half century, 1930-1982
title_short C-reactive protein – My perspective on its first half century, 1930-1982
title_sort c reactive protein my perspective on its first half century 1930 1982
topic C-reactive protein
acute phase response
complement
phagocytosis
Rockefeller Institute
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1150103/full
work_keys_str_mv AT irvingkushner creactiveproteinmyperspectiveonitsfirsthalfcentury19301982